Folgen
John R McLaughlin
John R McLaughlin
University of Toronto
Bestätigte E-Mail-Adresse bei utoronto.ca
Titel
Zitiert von
Zitiert von
Jahr
What is subjective global assessment of nutritional status?
AS Detsky, JR McLaughlin, JP Baker, N Johnston, S Whittaker, ...
Journal of parenteral and enteral nutrition 11 (1), 8-13, 1987
47591987
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
EARLY BREAST CANCER TRIALISTS'COLLABORATIVE GROUP
The Lancet 339 (8784), 1-15, 1992
26801992
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21571998
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
RJ Hung, JD McKay, V Gaborieau, P Boffetta, M Hashibe, D Zaridze, ...
Nature 452 (7187), 633-637, 2008
14802008
STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement
J Little, JPT Higgins, JPA Ioannidis, D Moher, F Gagnon, E Von Elm, ...
Genetic Epidemiology: The Official Publication of the International Genetic …, 2009
14272009
Effects of radiotherapy and surgery in early breast cancer—an overview of the randomized trials
Early Breast Cancer Trialists' Collaborative Group
N Engl j med 1995 (333), 1444-1456, 1995
12341995
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
HA Risch, JR McLaughlin, DEC Cole, B Rosen, L Bradley, E Kwan, ...
The American Journal of Human Genetics 68 (3), 700-710, 2001
12182001
SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY-133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN. Part 2.
O Abe, R Abe, K Asaishi, K Enomoto, T Hattori, Y Ino, K Kikuchi, ...
Lancet 339 (8785), 71-85, 1992
10881992
Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate
KZ Guyton, D Loomis, Y Grosse, F El Ghissassi, L Benbrahim-Tallaa, ...
The Lancet Oncology 16 (5), 490-491, 2015
10302015
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin–cohort study in Ontario, Canada
HA Risch, JR McLaughlin, DEC Cole, B Rosen, L Bradley, I Fan, J Tang, ...
Journal of the National Cancer Institute 98 (23), 1694-1706, 2006
9182006
Predicting cardiac complications in patients undergoing non-cardiac surgery
AS Detsky, HB Abrams, JR McLaughlin, DJ Drucker, Z Sasson, ...
Journal of general internal medicine 1 (4), 211-219, 1986
9121986
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24
BW Zanke, CMT Greenwood, J Rangrej, R Kustra, A Tenesa, ...
Nature genetics 39 (8), 989-994, 2007
8202007
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
6442013
Lung cancer susceptibility locus at 5p15. 33
JD McKay, RJ Hung, V Gaborieau, P Boffetta, A Chabrier, G Byrnes, ...
Nature genetics 40 (12), 1404-1406, 2008
6312008
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma
MT Landi, N Chatterjee, K Yu, LR Goldin, AM Goldstein, M Rotunno, ...
The american journal of human genetics 85 (5), 679-691, 2009
5972009
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007
S Walters, C Maringe, MP Coleman, MD Peake, J Butler, N Young, ...
Thorax 68 (6), 551-564, 2013
5952013
Ovarian ablation in early breast cancer: overview of the randomised trials
EBCTC Group
Lancet 348 (9036), 1189-1196, 1996
5891996
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
JD McKay, RJ Hung, Y Han, X Zong, R Carreras-Torres, DC Christiani, ...
Nature genetics 49 (7), 1126-1132, 2017
5152017
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
S Zhang, R Royer, S Li, JR McLaughlin, B Rosen, HA Risch, I Fan, ...
Gynecologic oncology 121 (2), 353-357, 2011
4942011
Non-Hodgkin’s lymphoma and specific pesticide exposures in men: cross-Canada study of pesticides and health
HH McDuffie, P Pahwa, JR McLaughlin, JJ Spinelli, S Fincham, ...
Cancer Epidemiology Biomarkers & Prevention 10 (11), 1155-1163, 2001
4442001
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20